KORU Medical Systems (KRMD) Cash & Equivalents (2010 - 2026)

KORU Medical Systems (KRMD) has reported Cash & Equivalents for 13 consecutive years, with $8.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents rose 0.73% year-over-year to $8.8 million; the TTM figure through Mar 2026 stood at $8.8 million (up 0.73% YoY), while the FY2025 annual figure was $8.9 million, down 7.4% from the prior year.
• Cash & Equivalents slipped to $8.8 million in Q1 2026 per KRMD's latest filing, from $8.9 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $22.6 million in Q1 2022 and bottomed at $8.1 million in Q2 2025.
• Historically, Cash & Equivalents has averaged $12.0 million across 5 years, with a median of $10.8 million in 2023.
• Annual changes were most pronounced in 2023 — Cash & Equivalents slumped 45.85% — and 2026, when it increased 0.73%.
• KORU Medical Systems' Cash & Equivalents stood at $17.4 million in 2022, then sank by 34.04% to $11.5 million in 2023, then slipped by 16.56% to $9.6 million in 2024, then fell by 7.4% to $8.9 million in 2025, then slipped by 0.81% to $8.8 million in 2026.
• Business Quant data shows KRMD's Cash & Equivalents at $8.8 million in Q1 2026, $8.9 million in Q4 2025, and $8.5 million in Q3 2025.